Globalpharma, a leading UAE-based pharmaceutical manufacturer and a subsidiary of Dubai Investments PJSC, has partnered with India’s ZIM Laboratories to introduce EU-certified Oral Dispersible Film (ODF) technology to the region.
The collaboration was officially announced during AIM Congress 2025, held from April 7–9 in Dubai.
ODF technology, recognised for its patient-friendly format—thin, fast-dissolving strips that require no water—offers an ideal solution for children, the elderly, and individuals with swallowing difficulties. ZIM Labs’ proprietary formulation is EU-GMP certified, meeting rigorous international standards for quality and safety.
The agreement was signed in the presence of Dr. Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade and Chairman of the Emirates Drug Establishment. Signatories included Mohammed Saeed Al Raqbani, General Manager of Dubai Investments Industries and Board Director at Globalpharma, and Zulfiquar Kamal, Promoter & Finance Director at ZIM Labs.
“This partnership is a transformative step for Globalpharma,”
said Al Raqbani.
“It reinforces our vision to drive healthcare innovation and position the UAE as a regional leader in advanced drug manufacturing.”
Dr. Basem Al-Barahmeh, General Manager of Globalpharma, added,
“By localising ODF production, we’re not only enhancing treatment accessibility but also setting a new regional standard in pharmaceutical manufacturing.”
ZIM Labs’ Kamal echoed the sentiment, calling the move a “milestone in expanding access to next-gen drug delivery systems across the GCC.”
Globalpharma’s dedicated ODF production line already includes ten products in development, reinforcing the UAE’s growing role in shaping global pharma innovation.
News Source: MSL
